AstraZeneca resumes COVID-19 vaccine trial after U.K. green light

Pharma giant AstraZeneca on Saturday said it had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a U.K. volunteer falling ill.